Ligand Pharmaceuticals Inc
LGNDNasdaqCIK 886163HealthcareFiscal year ends Dec 31
Reports and events: 477 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:47 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000886163-26-000060 |
| 2026-10-2907:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-26-000058 |
| 2026-09-2407:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0000886163-26-000054 |
| 2026-09-2207:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-26-000050 |
| 2026-09-0216:08 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000886163-26-000048 |
| 2026-08-0716:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000886163-26-000044 |
| 2026-08-0607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-26-000041 |
| 2026-07-1409:20 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-302660 |
| 2026-06-2517:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-282990 |
| 2026-06-2207:11 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276694 |
| 2026-06-0916:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000886163-26-000038 |
| 2026-05-1809:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-228003 |
| 2026-05-0816:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000886163-26-000034 |
| 2026-05-0707:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-26-000030 |
| 2026-05-0121:15 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-202033 |
| 2026-04-3016:41 ET | 8-K | 1.02 Termination of a material agreement | 0000886163-26-000027 |
| 2026-04-2709:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events | 0001193125-26-179529 |
| 2026-04-2116:02 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0000886163-26-000021 |
| 2026-02-2716:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000886163-26-000006 |
| 2026-02-2607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-26-000003 |
| 2025-12-1816:11 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-25-324830 |
| 2025-11-1016:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-274432 |
| 2025-11-0716:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000886163-25-000063 |
| 2025-11-0607:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-25-000058 |
| 2025-09-1617:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-205147 |
| 2025-08-1416:41 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-180841 |
| 2025-08-1107:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-177452 |
| 2025-08-0816:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000886163-25-000051 |
| 2025-08-0707:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-25-000047 |
| 2025-07-0316:05 ET | SCHEDULE 13D | Ownership report, active investor | 0000950170-25-093838 |
| 2025-07-0207:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-25-000042 |
| 2025-06-0916:03 ET | 8-K | 5.07 Shareholder vote results | 0000886163-25-000040 |
| 2025-05-0916:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000886163-25-000036 |
| 2025-05-0807:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-25-000033 |
| 2025-04-2216:07 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000886163-25-000025 |
| 2025-04-1706:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-25-000020 |
| 2025-02-2816:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000886163-25-000012 |
| 2025-02-2707:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-25-000008 |
| 2025-02-2516:02 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-25-000003 |
| 2024-11-0816:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000886163-24-000078 |
| 2024-11-0707:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-24-000074 |
| 2024-08-0716:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000886163-24-000071 |
| 2024-08-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886163-24-000067 |
| 2024-08-0217:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000886163-24-000064 |
| 2024-07-1717:10 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0000886163-24-000061 |
| 2024-07-1016:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000886163-24-000059 |
| 2024-07-0807:38 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886163-24-000053 |
| 2024-06-2709:10 ET | 8-K | 8.01 Other events | 0000886163-24-000051 |
| 2024-06-1817:14 ET | 8-K | 8.01 Other events | 0000886163-24-000047 |
| 2024-06-1716:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000886163-24-000045 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:58 ET. Listed shows no prices and gives no investment advice.